ARCHIVES

OMB Cut $150 Million From NCI Request

This article is from The Cancer Letter archive.

Vol. 01 No. 07 | March 22, 1974

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Approved By NCI

November 28, 2003

For R01s, 195 or P01s Center Funds Up By $600,000

May 22, 1981

FDA Approves Gemzar For Ovarian Cancer, Contradicting ODAC Recommendation; Continues Agency Trend to Recognize Progression-Free Survival As An Endpoint.

July 21, 2006

Panel Recommends Peer Review “Fine Tuning” Changes Including Mandatory Service By All NIH Grantees

January 6, 1984

What Should NCI Do When Center Directors Leave? Kimes Asks

July 24, 1992

FDA Moves To Revoke Avastin’s Breast Cancer Accelerated Approval, Genentech Vows To Fight

December 17, 2010